ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,149, issued on March 31, was assigned to L&L Bio Co. Ltd., Ningbo, China (Shanghai).
"Antibody and bispecific antibody targeting LAG-3 and use thereof" was invented by Jiajian Liu (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a LAG-3 binding protein, comprising a light chain variable region and/or a heavy chain variable region. The light chain variable region comprises a CDR1 having an amino acid sequence as shown in SEQ ID NO: 5, a CDR2 having an amino acid sequence as shown in SEQ ID NO: 6, and/or a CDR3 having an amino acid sequence as shown in SEQ ID NO: 7. The heavy chain variable region comprises a CDRI having an amino...